Abiopharma

🔍 HERRINGER FRANK C (Director)

Company: SCHWAB CHARLES CORP (SCHW)

Report Date: 2026-04-28

Detailed Transactions and Holdings:

• Acquired 7,866 shares of Common Stock at $28.96 per share (Direct)
  Date: 2026-04-28 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,666.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,520 shares of Common Stock at $90.6006 per share (Direct)
  Date: 2026-04-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 177,508.00 | transaction_form_type: 4 | Footnotes: F2, F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-28 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 50,625.00
• Sold 7,866 shares of Nonqualified Stock Option (right to buy) at $28.96 per share (Derivative)
  Date: 2026-04-28 | Code: M | Expires: 2026-05-19 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Reflects the contribution of the shares received upon exercise of the option to a revocable trust.
• F2: This transaction was executed in multiple trades at prices ranging from $90.60 to $90.615. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: The option was granted under the company's 2013 Stock Incentive Plan and vested 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date.